<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Clinical Living on Medium]]></title>
        <description><![CDATA[Stories by Clinical Living on Medium]]></description>
        <link>https://medium.com/@clinicalliving?source=rss-f0cc8682fe21------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*dmbNkD5D-u45r44go_cf0g.png</url>
            <title>Stories by Clinical Living on Medium</title>
            <link>https://medium.com/@clinicalliving?source=rss-f0cc8682fe21------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 22:55:13 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@clinicalliving/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[What Seeing Family Can Remind You About Your Health]]></title>
            <link>https://clinicalliving.medium.com/what-seeing-family-can-remind-you-about-your-health-5619bd410bbf?source=rss-f0cc8682fe21------2</link>
            <guid isPermaLink="false">https://medium.com/p/5619bd410bbf</guid>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[clinical-research]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Clinical Living]]></dc:creator>
            <pubDate>Wed, 18 Nov 2026 17:46:01 GMT</pubDate>
            <atom:updated>2026-11-18T17:46:01.603Z</atom:updated>
            <content:encoded><![CDATA[<p>There is a version of someone that exists only in memory. The way your father moved around a kitchen ten years ago. How your mother sounded on the phone before the medication changed. A sibling at a certain age, full of energy you have not seen from them in a while.</p><p>You carry those versions without realizing it. And then you see the person in front of you, and something registers that would not have registered over the phone or on a video call.</p><p>Time with family has a way of surfacing observations that ordinary distance keeps hidden. Not because anything dramatic has happened, but because being in the same room with someone after a gap resets your baseline. You notice the difference between who they were and who they are now in a way that gradual change makes impossible from up close.</p><p>This is not about monitoring people you love or arriving at family gatherings with a checklist. It is about paying attention to what is actually in front of you and knowing that what you notice might be worth following up on.</p><p>The observations that matter are rarely dramatic. They tend to be quieter than that. Someone moving more carefully than they used to. Fatigue that seems to have settled in rather than passing through. A subject that gets changed whenever it comes up. A prescription bottle on the counter you have not seen before.</p><p>None of those things are a diagnosis. But they are signals, and the people closest to someone are often the first to catch them, sometimes before the person themselves is ready to acknowledge that something has shifted.</p><p>The harder part is knowing what to do with what you notice. Most people file it away and tell themselves they will bring it up when the time is right. The time has a way of not arriving. The next visit comes, the same observation surfaces, and the window keeps moving.</p><p>If something is worth noticing, it is probably worth saying something about, even if the conversation feels awkward. You do not need to have answers or recommendations ready. A simple observation, offered without alarm, is often enough to open a door that the other person was waiting for someone to open.</p><p>For some families, those conversations eventually lead to questions about treatment options, what research exists around a condition, or whether a clinical trial might be worth looking into. Those conversations rarely start with the words clinical trial. They start with someone noticing something and deciding it was worth mentioning.</p><p>The time with people you love is finite and irregular. Being present for it means being actually present, paying attention to the person in front of you rather than the version you carry in your head.</p><p>What you notice when you do that might not amount to anything. But sometimes it does.</p><p>More at clinicalliving.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5619bd410bbf" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Questions Worth Asking Before You Consider a Clinical Trial]]></title>
            <link>https://clinicalliving.medium.com/questions-worth-asking-before-you-consider-a-clinical-trial-127ee3f9a813?source=rss-f0cc8682fe21------2</link>
            <guid isPermaLink="false">https://medium.com/p/127ee3f9a813</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[Clinical Living]]></dc:creator>
            <pubDate>Wed, 04 Nov 2026 17:46:02 GMT</pubDate>
            <atom:updated>2026-11-04T17:46:02.000Z</atom:updated>
            <content:encoded><![CDATA[<p>Most people who look into clinical trials go into their first conversation with a research team underprepared. Not because they are not intelligent or motivated, but because nobody told them what to ask. The questions below are the ones worth having answers to before you make any decisions.</p><p>This is not a comprehensive checklist for every possible situation. It is a starting point for getting oriented, understanding what you are considering, and making sure the information you need is on the table before anything else happens.</p><ul><li>What phase is this trial, and what does that mean for what is already known about the treatment?</li><li>What is the primary purpose of this study? Is it testing safety, effectiveness, or comparing this treatment to an existing one?</li><li>What are the known risks and potential benefits based on what the research has shown so far?</li><li>Is there a placebo involved? If so, what are the chances I would be in the placebo group, and would I be told?</li><li>What does participation actually look like week to week? How many visits, how long, and where?</li><li>Can any part of this trial be done remotely, or does everything require in-person visits?</li><li>What happens to my regular care while I am participating? Will my existing doctor still be involved?</li><li>Who is sponsoring this trial, and who is responsible for my care if something goes wrong?</li><li>What are the eligibility requirements, and do I meet all of them?</li><li>What does the informed consent process involve, and how much time will I have to review it before deciding?</li><li>Can I leave the trial if I change my mind, and what happens to my care if I do?</li><li>Will I be told the results of the trial when it concludes?</li><li>Are there any costs to me as a participant, and are travel or time costs covered?</li><li>Who do I contact if I have questions or concerns after I enroll?</li></ul><p>You do not need to ask every one of these in a single conversation. But you should feel confident that you have answers to all of them before you sign anything or commit to participating.</p><p>A research team that is running a well-designed, ethical trial will have clear answers to every question on this list. If an answer is vague, incomplete, or you are made to feel like the question is inconvenient, that is information worth paying attention to.</p><p>Clinical Living’s education center covers each of these areas in more detail for anyone who wants to understand the context behind the questions before they ask them.</p><p><em>More at clinicalliving.com</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=127ee3f9a813" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Four Phases of a Clinical Trial, Explained]]></title>
            <link>https://clinicalliving.medium.com/the-four-phases-of-a-clinical-trial-explained-36519a804773?source=rss-f0cc8682fe21------2</link>
            <guid isPermaLink="false">https://medium.com/p/36519a804773</guid>
            <category><![CDATA[research]]></category>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[phase]]></category>
            <dc:creator><![CDATA[Clinical Living]]></dc:creator>
            <pubDate>Wed, 21 Oct 2026 16:41:01 GMT</pubDate>
            <atom:updated>2026-10-21T16:41:01.583Z</atom:updated>
            <content:encoded><![CDATA[<p>Clinical trials are described in phases, and if you have ever looked into a trial and seen Phase 1, Phase 2, or Phase 3 listed without further explanation, you already know how little that tells you on its own. Each phase has a distinct purpose and a different profile of participants, risks, and goals. Understanding what each one actually involves changes how you read trial listings and what questions you know to ask.</p><p><strong>Phase 1: Is it safe?</strong><br>Phase 1 trials are the first time a new treatment is tested in people. The primary question is whether the treatment is safe at various doses and how the body processes it. These studies are small, typically involving a few dozen participants, and they focus on identifying side effects, understanding how the drug moves through the body, and establishing what dose range appears to be workable.</p><p>Phase 1 trials are not primarily designed to test whether the treatment works. That comes later. The goal here is safety and tolerability. Participants in Phase 1 trials are often healthy volunteers, though in some cases, particularly in cancer research, they are patients who have not responded to other treatments.</p><p><strong>Phase 2: Does it work?</strong><br>If a treatment clears Phase 1, it moves into Phase 2, where the question shifts to effectiveness. Does this treatment do what it is supposed to do, and does it work at the doses identified in Phase 1? Phase 2 trials are larger, typically involving several hundred participants, and they focus on a specific condition or patient population.</p><p>Safety monitoring continues throughout Phase 2. Researchers are watching for side effects and refining their understanding of who responds well to the treatment and under what conditions. Not every treatment that enters Phase 2 moves forward. Many stop here if the effectiveness data is not strong enough to justify continued development.</p><p><strong>Phase 3: Is it better than what already exists?</strong><br>Phase 3 trials are the large-scale studies that most people picture when they think about clinical research. These trials compare the new treatment against the current standard of care, or against a placebo when no standard treatment exists, across a large and diverse participant population that can number in the thousands.</p><p>The goal is to generate the kind of statistically significant evidence that regulatory agencies require before approving a treatment for widespread use. Phase 3 trials are closely monitored, often run at multiple sites simultaneously, and can take several years to complete. A treatment that performs well in Phase 3 is what gets submitted to the FDA for approval.</p><p><strong>Phase 4: What happens after approval?</strong><br>Phase 4 trials happen after a treatment has been approved and is already available to patients. They are designed to monitor how the treatment performs in the broader population over the long term, to identify any rare side effects that did not appear in earlier trials, and to explore whether the treatment might be effective for other conditions or populations.</p><p>Participation in a Phase 4 trial looks different from earlier phases. The treatment is already approved, which means participants have access to something that is already considered safe and effective enough for general use. The research is focused on building out the complete picture of how that treatment behaves in the real world over time.</p><p>Why the phase matters to you<br>Knowing the phase of a trial you are considering tells you a lot about what to expect. It tells you how much is already known about the treatment, what stage of development the research is in, how many other people are involved, and what the study is primarily trying to find out.</p><p>It does not tell you everything, and it should not be the only thing you look at. But it is one of the most useful pieces of context you can have when you are trying to understand whether a specific trial is worth exploring further.</p><p>More at clinicalliving.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=36519a804773" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What Clinical Trials Actually Are (And What They Are Not)]]></title>
            <link>https://clinicalliving.medium.com/what-clinical-trials-actually-are-and-what-they-are-not-9ec2b5d96d50?source=rss-f0cc8682fe21------2</link>
            <guid isPermaLink="false">https://medium.com/p/9ec2b5d96d50</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[education]]></category>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[Clinical Living]]></dc:creator>
            <pubDate>Wed, 07 Oct 2026 22:38:50 GMT</pubDate>
            <atom:updated>2026-10-07T22:38:50.756Z</atom:updated>
            <content:encoded><![CDATA[<p>Most people have a version of clinical trials in their head that was assembled from fragments. A news story about a breakthrough drug. A scene from a medical drama. Something a relative mentioned once when they were sick. The version they have is usually incomplete, sometimes wrong, and almost always skewed toward the dramatic.</p><p>That matters because the gap between what people think clinical trials are and what they actually are is one of the main reasons people never look into them. If your mental image of a trial involves experimental procedures, unknown risks, and researchers who treat patients like data points, you are going to have a very different reaction to the idea of participating than someone whose understanding is more accurate.</p><p>So here is a more accurate version.</p><p>A clinical trial is a structured research study that tests whether a medical intervention works and is safe. That intervention could be a drug, a device, a behavioral approach, a diagnostic tool, or a preventive measure. Trials are conducted according to a pre-approved protocol that specifies exactly who can participate, what will happen during the study, what data will be collected, and how that data will be analyzed.</p><p>They are not improvised. They are not run by researchers making it up as they go. Every trial that runs in the United States must be reviewed and approved by an independent ethics board before it begins, and that board continues to monitor the study while it is active. If something raises a safety concern at any point, the board has the authority to pause or stop the trial entirely.</p><p>Participation is always voluntary. Before anyone joins, they go through a process called informed consent, where they are told exactly what the study involves, what the known risks are, what the potential benefits might be, and what their rights are as a participant. They can ask questions. They can take time to decide. And if they join and change their mind at any point, they can leave with no penalty and no effect on their ongoing care.</p><p>That framework is not a courtesy. It is a legal requirement that was built over decades in direct response to cases where research harmed people because those protections did not exist. Every right a participant has today was hard won.</p><p>Trials are also not a last resort. That assumption is one of the most persistent misconceptions around clinical research, and it shapes how people approach the topic before they ever look into specifics. In reality, trials study treatments across every stage of a condition, from prevention to early intervention to long-term management. Some trials are looking specifically for participants who have never been treated. Some are open to healthy individuals. The range is far broader than most people assume.</p><p>They are also not all happening at major research hospitals hours away from where most people live. Decentralized trial models, which use telehealth visits, home delivery of study materials, and wearable devices to collect data, have made participation possible for people who could not have managed the logistics of traditional trial participation even a few years ago.</p><p>None of this means clinical trials are right for everyone or that participation is always the obvious next step. There are real eligibility requirements, real time commitments, and real uncertainties involved in any study. Those things are worth understanding clearly.</p><p>But they are worth understanding from an accurate starting point. The version of clinical trials that keeps most people from ever looking into them is not the real one. The real one is more structured, more protective, and more accessible than the version most people carry around.</p><p>That is worth knowing, even if you never participate in a trial. And if you ever face a health situation where participation might be worth considering, it is worth knowing before that moment arrives.</p><p>More at clinicalliving.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9ec2b5d96d50" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>